| {"0": "Electron transport chain oxphos system in mitochondria", "1": "Nonalcoholic fatty liver disease", "2": "Sphingolipid metabolism integrated pathway", "3": "Sphingolipid metabolism overview", "4": "Sphingolipid metabolism in senescence", "5": "Sphingolipid pathway", "6": "Ferroptosis", "7": "Mecp2 and associated rett syndrome", "8": "Cholesterol metabolism with bloch and kandutschrussell pathways", "9": "Oxidative phosphorylation", "10": "Mitochondrial complex iii assembly", "11": "Mitochondrial complex i assembly model oxphos system", "12": "Cholesterol biosynthesis pathway", "13": "S1p receptor signal transduction", "14": "Degradation pathway of sphingolipids including diseases", "15": "Influence of laminopathies on wnt signaling", "16": "Overlap between signal transduction pathways contributing to lmna laminopathies", "17": "Metapathway biotransformation phase i and ii", "18": "Mitochondrial immune response to sarscov2", "19": "Alzheimers disease and mirna effects", "20": "Alzheimers disease", "21": "Circadian rhythm genes", "22": "Orexin receptor pathway", "23": "Sterol regulatory elementbinding proteins srebp signaling", "24": "7oxoc and 7betahc pathways", "25": "Pi3kaktmtor signaling pathway and therapeutic opportunities", "26": "Factors and pathways affecting insulinlike growth factor igf1akt signaling", "27": "Vitamin d receptor pathway", "28": "Vitamin dsensitive calcium signaling in depression", "29": "Mrna processing", "30": "Notch signaling"} |